Relationship between CMV and graft rejection after heart transplantation

Transplant International

Volumn 9, Issue SUPPL. 1, 1996, Pages

  Decoene, C ^a   Pol, A ^a   Dewilde, A ^b   Wattre, P ^b   Coppin, M C ^b   Gosselin, B ^b   Stankowiak, C ^b   Warembourg, H ^b  

^a Serv d'Anesthesie Reanimation C   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Antiviral therapy; CMV; Graft rejection; Heart transplantation

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; LYMPHOCYTE ANTIBODY;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0029903339     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb01620.x     Document Type: Article

References (1)

1. The International Society for Heart Transplantation, Billingham ME, Cary NR, Hammond ME, et al (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung transplantation: Heart Rejection Study Group. J Heart Transplant 9: 587-593